Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | |
|---|---|---|
| Operating cash flow (direct method) | ||
| Cash income from operating activities | ||
| Cash paid | -607.35%-3.9M | -551.28K |
| Payments to suppliers for goods and services | -231.39%-1.83M | ---551.28K |
| Other cash payments from operating activities | ---2.07M | ---- |
| Direct interest paid | ---- | ---24.07K |
| Direct interest received | 2,723.93%259.01K | --9.17K |
| Operating cash flow | -543.00%-3.64M | ---566.18K |
| Investing cash flow | ||
| Cash flow from continuing investing activities | 59.10%-157.21K | -384.36K |
| Capital expenditure reported | ---- | ---65.19K |
| Net PPE purchase and sale | ---157.21K | ---- |
| Net business purchase and sale | ---- | ---319.17K |
| Cash from discontinued investing activities | ||
| Investing cash flow | 59.10%-157.21K | ---384.36K |
| Financing cash flow | ||
| Cash flow from continuing financing activities | -74.65%2.73M | 10.76M |
| Net common stock issuance | -74.65%2.73M | --10.76M |
| Cash from discontinued financing activities | ||
| Financing cash flow | -74.65%2.73M | --10.76M |
| Net cash flow | ||
| Beginning cash position | 980,664,600.00%9.81M | --1 |
| Current changes in cash | -110.92%-1.07M | --9.81M |
| Effect of exchange rate changes | -6,122.25%-21.53K | ---346 |
| End cash Position | -11.14%8.71M | --9.81M |
| Free cash from | -501.50%-3.8M | ---631.37K |
| Accounting Standards | US-GAAP | US-GAAP |